Evaluation of Pralidoxime Use in an Iranian Teaching Referral Hospital

被引:1
作者
Mohammadi, Ali Banagozar [1 ]
Nahandi, Maryam Zaare [2 ]
Raad, Negin [1 ]
Javani, Siroos [1 ]
Gharekhani, Afshin [3 ,4 ]
机构
[1] Tabriz Univ Med Sci, Sina Educ Hosp, Med Philosophy & Hist Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Sina Educ Hosp, Chron Kidney Dis Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Pharm, Drug Appl Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Fac Pharm, Dept Clin Pharm Pharmacotherapy, Tabriz, Iran
关键词
Antidote; Organophosphate; Poisoning; Pralidoxime;
D O I
10.15171/PS.2018.12
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Organophosphorus (OP) poisonings, a common source of pesticide poisoning, are an important cause of morbidity and mortality in the developing countries. Combination therapy with atropine and oxime is a common practice in the management of OP poisoning. However, the additive benefit of using pralidoxime in addition to atropine remains controversial. Due to inappropriate and widespread use of this relatively expensive and low available antidote, we aimed to evaluate its usage in an Iranian teaching hospital. Methods: Medical files of patients with pesticide poisoning who had been admitted to the poisoning ward between September 2013 and September 2014 were reviewed. Patients with definite diagnosis of OPs poisoning were selected to evaluate rational use of pralidoxime in their treatment regimen. Data were collected using a checklist containing demographic, clinical, and pars clinical characteristics, as well as the type of pesticide poisoning. Appropriateness of the pralidoxime therapy was determined based on clinical practice guideline and endorsed by an attending medical toxicologist. Results: 68.8% of patients had been poisoned with insecticides, 27.1% with aluminum phosphide. 2.1% with herbicides. and 2% with rodenticides. respectively. OPs were responsible for 43.8% of all poisoning. All patients with OPs poisoning received pralidoxime after they had been admitted to emergency department. while only 55% of them were eligible to receive pralidoxime. Moreover, pralidoxime had been administered for 59% of patients with non-OPs poisoning, which all of them were clinically inappropriate. Conclusion: The use of pralidoxime in the northwest of Iran is not appropriate and thus, it is highly recommended that a patient-tailored treatment guideline be provided and implemented regionally.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 22 条
  • [1] Pharmacotherapy to protect the neuromuscular junction after acute organophosphorus pesticide poisoning
    Bird, Steven B.
    Krajacic, Predrag
    Sawamoto, Keigo
    Bunya, Naofumi
    Loro, Emanuele
    Khurana, Tejvir S.
    [J]. COUNTERMEASURES AGAINST CHEMICAL THREATS, 2016, 1374 : 86 - 93
  • [2] Bird Steven B, 2010, Front Biosci (Schol Ed), V2, P209
  • [3] Oximes for acute organophosphate pesticide poisoning
    Buckley, Nick A.
    Eddleston, Michael
    Li, Yi
    Bevan, Marc
    Robertson, Jane
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (02):
  • [4] Organophosphate toxicology: Safety aspects of nonacetylcholinesterase secondary targets
    Casida, JE
    Quistad, GB
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (08) : 983 - 998
  • [5] Management of acute organophosphorus pesticide poisoning
    Eddleston, Michael
    Buckley, Nick A.
    Eyer, Peter
    Dawson, Andrew H.
    [J]. LANCET, 2008, 371 (9612) : 597 - 607
  • [6] Pralidoxime in Acute Organophosphorus Insecticide Poisoning-A Randomised Controlled Trial
    Eddleston, Michael
    Eyer, Peter
    Worek, Franz
    Juszczak, Edmund
    Alder, Nicola
    Mohamed, Fahim
    Senarathna, Lalith
    Hittarage, Ariyasena
    Azher, Shifa
    Jeganathan, K.
    Jayamanne, Shaluka
    von Meyer, Ludwig
    Dawson, Andrew H.
    Sheriff, Mohamed Hussain Rezvi
    Buckley, Nick A.
    [J]. PLOS MEDICINE, 2009, 6 (06)
  • [7] ANTIDOTAL THERAPY OF SEVERE ACUTE ORGANO-PHOSPHATE POISONING - A MULTIHOSPITAL STUDY
    FINKELSTEIN, Y
    KUSHNIR, A
    RAIKHLINEISENKRAFT, B
    TAITELMAN, U
    [J]. NEUROTOXICOLOGY AND TERATOLOGY, 1989, 11 (06) : 593 - 596
  • [8] Jaga Kushik, 2003, Rev Panam Salud Publica, V14, P171, DOI 10.1590/S1020-49892003000800004
  • [9] Organophosphate pesticides: Biochemistry and clinical toxicology
    Kwong, TC
    [J]. THERAPEUTIC DRUG MONITORING, 2002, 24 (01) : 144 - 149
  • [10] Ligtenstein D.A., 2000, EMERGEN MED, V12, P22, DOI [DOI 10.1046/J.1442-2026.2000.00087.X, 10.1046/j.1442-2026.2000.00087.x]